Application of microalgal fucoxanthin for the reduction of colon cancer risk: Inhibitory activity of fucoxanthin against β-glucuronidase and DLD-1 cancer cells

Natural Product Communications

Volumn 9, Issue 7, 2014, Pages 921-924

  Kawee ai, Arthitaya ^a   Kim, Sang Moo ^a  

^a Gangneung Wonju National University   (South Korea)

Author keywords

Colon cancer; Fucoxanthin; Microalgae; Phaeodactylum tricornutum; Glucuronidase inhibitor

Indexed keywords

BETA GLUCURONIDASE; FUCOXANTHIN;

ARTICLE; CANCER CELL LINE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; ENZYME INHIBITION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; MICROALGA; NONHUMAN; PHAEODACTYLUM TRICORNUTUM; RISK REDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; COLONIC NEOPLASMS; GLUCURONIDASE; HUMANS; MICROALGAE; XANTHOPHYLLS;

EID: 84905117942     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Levvy GA, Conchie J. (1966) β-Glucuronidase and the hydrolysis of glucuronides. In Glucuronic acid. Dutton GJ. (Ed.). Academic Press, New York, 301-364.
2. Sekikawa C, Kurihara H, Goto K, Takahashi K. (2002) Inhibition of β-glucuronidase by extracts of Chondria crassicaulis. Bulletin of Fisheries Science Hokkaido University, 53, 27-30.
3. Maruti SS, Li L, Chang J-L, Prunty J, Schwarz Y, Li SS, King IB, Potter JD, Lampe JW. (2010) Dietary and demographic correlates of serum β-glucuronidase activity. Nutrition and Cancer, 62, 208-219.
4. Reddy BS, Wynder EL. (1973) Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. Journal of the National Cancer Institute, 50, 1437-1442.
5. Rafter J, Govers M, Martel P, Pannemans D, Pool-Zobel B, Rechkemmer G, Rowland I, Tuijtelaars S, van Loo J. (2004) PASSCLAIM- Diet-related cancer. European Journal of Nutrition, 43, 47-84.
6. Nawaz HR, Malik A, Khan PM, Shujaat S, Rahman AU. (2000) A novel β-glucuronidase inhibiting triterpenoid from Paeonia emodi. Chemical and Pharmaceutical Bulletin, 48, 1771-1773.
7. Kim DH, Jin YH, Park JB, Kobashi K. (1994) Silymarin and its components are inhibitors of β-glucuronidase. Biological and Pharmaceutical Bulletin, 17, 443-445.
8. Safdar H, Atta-ur-Rahman, Choudhary MI, Khalid MK, Abbas Khan A. (2002) Two new cinnamic acid esters from marine brown alga Spatoglossum variable. Chemical and Pharmaceutical Bulletin, 50, 1297-1299.
9. Kim KY, Choi KS, Kurihara H, Kim SM. (2008) β-Glucuronidase inhibitory activity of bromophenols purified from Grateloupia elliptica. Food Science and Biotechnology, 17, 1110-1114.
10. Haugan JA, Aakermann R, Liaaen-Jensen S. (1992) Isolation of fucoxanthin and peridinin. Methods in Enzymology, 213, 231-245. (Pubitemid 23012219)
11. Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K. (2004) Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARγ ligand, troglitazone, on colon cancer cells. Biochemica et Biophysica Acta (BBA)-General Subjects, 1675, 113-119. (Pubitemid 39463260)
12. Kawee-ai A, Kuntiya A, Kim SM. (2013) Anticholinesterase and antioxidant activities of fucoxanthin purified from the microalga Phaeodactylum tricornutum. Natural Product Communications, 8, 1381-1386.
13. Lee HW, Choo MY, Bae EA, Kim DH. (2003) β-Glucuronidase inhibitor tectorigenin isolated from the flower of Pueraria thunbergiana protects carbon tetrachloride induced liver injury. Liver International, 23, 221-226.
14. Englert G, Bjørnland T, Liaaen-Jensen S. (1990) 1D and 2D NMR study of some allenic carotenoids of the fucoxanthin series. Magnetic Resonance in Chemistry, 28, 519-528.
15. Karunairatnam MC, Levvy GA. (1949) The inhibition of β-glucuronidase by saccharic acid and the role of the enzyme in glucuronide synthesis. Biochemical Journal, 44, 599-603.
16. Kim YM, Jeong YK, Wang MH, Lee WY, Rhee HI. (2005) Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia. Nutrition, 21, 756-761.
17. Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, Redinbo MR. (2010). Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science, 330, 831-835.
18. Longo C, Leo L, Leone A. (2012) Carotenoids, fatty acid composition and heat stability of supercritical carbon dioxide-extracted-oleoresins. International Journal of Molecular Science, 13, 4233-4254.
19. Boileau TWM, Boileau AC, Erdman JW. (2002) Bioavailability of all-trans and cis-isomers of lycopene. Experimental Biology and Medicine, 227, 914-919. (Pubitemid 35340347)
20. Schöllhammer I, Poll DS, Bickel MH. (1975) Liver microsomal beta-glucuronidase and UDP-glucuronyltransferase. Enzyme, 20, 269-276.
21. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. (1981). Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Research, 41, 1751-1756. (Pubitemid 11114567)
22. Jóźwik A, Śliwa-Jóźwik A, Koła̧taj A. (2005) The effect of administration of high doses of selected antioxidants upon the activity of beta-glucuronidase (-GL) in the liver, kidney and blood plasma of mice. Animal Science Papers and Reports, 23, 219-227.
23. Kurihara H, Mitani T, Kawabata J, Takahashi K. (1999) Two new bromophenols from red alga Odonthalia corymbifera. Journal of Natural Products, 62, 882-884. (Pubitemid 29296328)
24. Dixon M. (1953) The determination of enzyme inhibition constants. Biochemical Journal, 55, 170-171.
25. Lineweaver H, Burk D. (1934) The determination of enzyme dissociation constants. Journal of the American Chemical Society, 56, 658-666.
26. Yuan L, Wagatsuma C, Yoshida M, Miura T, Mukoda T, Fujii H, Sun B, Kim J-H, Surh Y-J. (2003) Inhibition of human breast cancer growth by GCP™ (genistein combined polysaccharide) in xenogeneic athymic mice: involvement of geniststein biotransformation by β-glucurosidase from tumor tissues. Mutation Research, 523-524, 5-62.